Chemotherapy-Induced Eyebrow Alopecia and Psychological Recovery: Permanent Micropigmentation as a Component of Multidisciplinary Oncological Rehabilitation

Background: Advances in oncology have significantly increased cancer survival rates, creating a growing population of patients who must cope with long-term physical and psychological consequences of treatment. One of the most visible outcomes of chemotherapy is hair loss, including eyebrow and eyelash alopecia, which may persist long after remission. Loss of eyebrows has a particularly strong psychosocial impact because the face plays a central role in identity, emotional expression, and social communication. Methods: This article presents a theoretical and clinical analysis of permanent micropigmentation (PM) as a restorative intervention for patients experiencing eyebrow alopecia after chemotherapy. Existing scientific literature on body image disturbance, psychosocial oncology, and aesthetic rehabilitation was reviewed to examine how visible appearance changes influence psychological well-being. The paper also proposes a structured rehabilitation approach that includes medical clearance, skin assessment, psychological screening, informed consent, and staged micropigmentation procedures with follow-up evaluation. Results: Evidence suggests that visible changes in facial appearance may lead to body image disruption, identity discontinuity, social anxiety, and decreased quality of life in cancer survivors. Restoration of eyebrows through permanent micropigmentation may significantly reduce these psychosocial stressors by improving self-recognition and confidence. Patients frequently report feeling that they “recognize themselves again” after the procedure, indicating restoration of body image integrity. Conclusion: Permanent micropigmentation should be considered not merely a cosmetic intervention but a supportive rehabilitative procedure within multidisciplinary oncology care. When performed under appropriate medical conditions and timing, PM may contribute to psychological recovery, improved social reintegration, and enhanced quality of life for patients recovering from cancer treatment.